Nuria Oliver, doctora por el Media Lab del MIT, Directora de ciencia de datos en Vodafone y Chief Data Scientist en DataPop Alliance habla sobre lo que es y no la IA.
Fuente: El Mundo
Seguir leyendo:
Read next
Health
GLP-1 Supply Expansions Alter Pharmaceutical Manufacturing Priorities
High demand for metabolic therapeutics drives unprecedented capital expenditure in sterile injectable drug manufacturing.
Health
Pharmaceutical Supply Chains Expand API Capacity for Metabolic Drugs
Active pharmaceutical ingredient manufacturers invest in continuous manufacturing to resolve global GLP-1 shortages.
Health
GLP-1 Weight-Loss Therapeutics Reshape Pharmaceutical Supply Chains
High demand for metabolic treatments creates manufacturing constraints and disrupts corporate wellness programs.
Health
Clinical Trials Accelerate Deployment of Continuous Biomarker Monitoring Devices
Healthcare providers are expanding trial protocols for non-invasive continuous monitors to track metabolic metrics beyond standard blood glucose…
Health
Targeted mRNA Platforms Focus on Autoimmune Conditions in Phase II Trials
Clinical trial data reveals promising results for antigen-specific mRNA therapies designed to suppress autoimmune responses without global immunosuppression.
Health
AI-Driven Macromolecular Analysis Accelerates Drug Discovery Pipelines
Biopharmaceutical firms leverage predictive protein folding algorithms to reduce early-stage drug target identification timelines by over forty percent.